Healthy Eating and Active Living (HEAL), Exploring Feasibility of a Lifestyle Intervention
HEAL
1 other identifier
interventional
19
1 country
1
Brief Summary
Lifestyle interventions combining nutrition, physical activity, and behavioral strategies are increasingly recognized for improving metabolic and psychological health, yet their translation into real-world settings remains limited. Key implementation factors such as feasibility, adherence, intervention fidelity, and the integration of complex assessment modalities are often underreported, despite being essential for scaling and clinical application. The Healthy Eating and Active Living (HEAL) study is a prospective, single-arm feasibility trial evaluating a structured, multimodal lifestyle intervention within a university research environment. The 12-week program integrates supervised progressive resistance training and structured nutritional guidance, delivered through existing infrastructure including the Center for Brain and Health, the Public Health Research Center, on-campus fitness facilities, and digital dietary monitoring tools. The exercise component consists of twice-weekly supervised, machine-based resistance training with standardized progression, while the nutritional component includes four weeks of meal provision followed by guided self-management. Participants complete a multimodal assessment battery at baseline, post-intervention, and 12-week follow-up, including body composition, blood biomarkers, gut microbiome analysis, fitness testing, wearable-based activity and sleep monitoring, self-reported measures, and resting-state functional magnetic resonance imaging (fMRI). The primary objective is to assess feasibility, including recruitment, retention, adherence, intervention fidelity, safety, acceptability, and data completeness. Secondary analyses explore pre-post changes in physiological, behavioral, and neuroimaging outcomes to inform future study design. The study is not powered to assess clinical efficacy. Findings will inform the design of larger trials and the application of the HEAL framework in clinical populations.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 16, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2026
CompletedFirst Submitted
Initial submission to the registry
March 24, 2026
CompletedFirst Posted
Study publicly available on registry
June 23, 2026
CompletedJune 23, 2026
June 1, 2026
1.5 years
March 24, 2026
June 22, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Feasibility of the multimodal lifestyle intervention
Feasibility will be assessed as the proportion of participants meeting predefined criteria across key domains, including retention rate (% of participants completing the 12-week intervention), exercise adherence (% of scheduled sessions attended), intervention fidelity (% adherence to predefined progression criteria), dietary adherence (% compliance with macronutrient targets assessed via Intake24), safety (incidence of adverse events), and data completeness (% of completed assessments across modalities).
Baseline to end of intervention (12 weeks), with additional assessment of data completeness at 12-week follow-up (24 weeks total)
Secondary Outcomes (10)
Change in body fat percentage measured by bioelectrical impedance analysis (InBody 720)
Baseline, 12 weeks, 24 weeks
Change in visceral fat level measured by bioelectrical impedance analysis (InBody 720)
Baseline, 12 weeks, 24 weeks
Change in cardiovascular fitness measured by Harvard Step Test Index Score
Baseline, 12 weeks, 24 weeks
Change in composite muscular strength score derived from standardized strength assessments
Baseline, 12 weeks, 24 weeks
Change in C-reactive protein concentration measured from blood samples
Baseline, 12 weeks, 24 weeks
- +5 more secondary outcomes
Study Arms (1)
HEAL Intervention
EXPERIMENTALParticipants underwent a 12-week multimodal lifestyle intervention combining supervised resistance training and structured nutritional guidance. The exercise component consisted of twice-weekly, 60-minute supervised, machine-based resistance training sessions following a standardized protocol with predefined progression criteria. The nutritional component included four weeks of meal provision tailored to individual maintenance energy requirements and macronutrient targets, followed by eight weeks of guided self-management. Participants were encouraged to maintain similar dietary patterns during the self-managed phase. Dietary intake was monitored using Intake24. A comprehensive multimodal assessment battery, including physiological, behavioral, and neuroimaging measures, was conducted at baseline, post-intervention, and at a 12-week follow-up.
Interventions
The intervention consisted of a 12-week multimodal lifestyle program integrating supervised resistance training and structured nutritional guidance. The exercise component involved twice-weekly, 60-min supervised sessions using standardized machine-based resistance training. Each session followed a fixed sequence targeting major muscle groups and included leg press, chest press, seated row, glute drive, lat pulldown, walking lunges, and one core exercise. Following a two-week familiarization phase, participants progressed according to predefined overload criteria, with resistance increased when target repetitions were achieved with proper technique. Sessions concluded with a short period of moderate cardiovascular activity. The nutritional component included an initial 4-week meal-provision phase, during which participants received meals five days per week tailored to individual maintenance energy requirements (BMR Ă— 1.2) and macronutrient targets (30% P, 40% C, 30% F)
Eligibility Criteria
You may qualify if:
- Adults aged 18 to 65 years
- Able to participate in moderate-intensity supervised resistance training
- Willing to comply with the 12-week intervention and associated assessments
- Able to provide biological samples (blood and stool) and complete behavioral assessments
- Able to provide written informed consent
You may not qualify if:
- Medical conditions contraindicating moderate resistance training (e.g., uncontrolled cardiovascular, respiratory, or musculoskeletal conditions)
- Current pregnancy or planned pregnancy during the study period
- Participation in another structured lifestyle, nutrition, or exercise intervention during the study period
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
New York University Abu Dhabi
Abu Dhabi, Abu Dhabi Emirate, 111, United Arab Emirates
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Bas Rokers, Professor
New York University Abu Dhabi
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Masking Details
- Although the study is conducted as an open-label, single-arm intervention, analysis of outcome measures is performed by researchers blinded to the timing of assessments. This includes blood biomarkers, stool-based metagenomic data, neuroimaging (fMRI) data, and behavioral questionnaire outcomes. Blinding is maintained during data processing and analysis to reduce potential bias in interpretation of results.
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 24, 2026
First Posted
June 23, 2026
Study Start
September 16, 2024
Primary Completion
February 28, 2026
Study Completion
February 28, 2026
Last Updated
June 23, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will not share
Individual participant data (IPD) will not be made publicly available due to the sensitive nature of the multimodal data collected, including neuroimaging, genetic (metagenomic), and detailed physiological and behavioral information, which may increase the risk of participant re-identification. In addition, data sharing is subject to institutional policies and ethical approvals governing data collected within a university research setting. De-identified data may be made available upon reasonable request, subject to appropriate data use agreements and ethical approval.